US Patent 11266694 Restimulation of cryopreserved tumor infiltrating lymphocytes
Patent 11266694 was granted and assigned to Iovance Biotherapeutics, Inc. on March, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11266694 Restimulation of cryopreserved tumor infiltrating lymphocytes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
